Growing community of inventors

Bondues, France

Dean Hum

Average Co-Inventor Count = 4.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 51

Dean HumRémy Hanf (9 patents)Dean HumRaphael Darteil (8 patents)Dean HumIngrid Dufour (8 patents)Dean HumRobert Walczak (2 patents)Dean HumCarole Belanger (1 patent)Dean HumBenoît Noel (1 patent)Dean HumCorinne Foucart (1 patent)Dean HumRaphaël Darteil (3 patents)Dean HumBenoit Noel (1 patent)Dean HumRemy Hanf (1 patent)Dean HumDean Hum (10 patents)Rémy HanfRémy Hanf (23 patents)Raphael DarteilRaphael Darteil (14 patents)Ingrid DufourIngrid Dufour (8 patents)Robert WalczakRobert Walczak (24 patents)Carole BelangerCarole Belanger (12 patents)Benoît NoelBenoît Noel (6 patents)Corinne FoucartCorinne Foucart (5 patents)Raphaël DarteilRaphaël Darteil (3 patents)Benoit NoelBenoit Noel (1 patent)Remy HanfRemy Hanf (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Genfit (10 from 67 patents)


10 patents:

1. 11191749 - Pharmaceutical compositions for combination therapy

2. 10792277 - Methods of treatment of fibrosis and cancers

3. 10722575 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders

4. 10350181 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders

5. 10022343 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders

6. 9782373 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders

7. 9585853 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders

8. 9221751 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders

9. 8895619 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders

10. 8772342 - Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/15/2025
Loading…